Alignment Labs™

Four rooms between an idea
and a launch plan.

Four facilitated executive sessions that take a new product launch from an unformed commercial position to a launch execution plan, one decision set at a time.

Each Lab produces the decisions the next one depends on. Run out of order, the later sessions spend their time rebuilding what the earlier ones should have settled.

Schedule an alignment discussion

The thesis underneath

The earliest failures leave no artifact

No rejection, no denial, no reversal. Nothing to count. A patient who is never identified generates no record anywhere in a commercial data set, because the prescription is never written.

A company can execute payer strategy, channel design and hub operations flawlessly and still under-launch, because the eligible population was never found.

Patient friction creates revenue leakage. Gross-to-net is the financial echo of how well the enterprise executed the patient journey.

The Labs exist to design that journey deliberately rather than inherit it.

How a Lab works

Three design rules

These are constraints on us, not promises to you. They are the reason a Lab produces a decision record rather than a deck.

Rule one

Decisions, not education

A Lab is a room where positions get taken and owners get named. Not a workshop, not a training session, not a readout. Every Lab is measured by what was decided in it, never by what was presented.

Rule two

No platform required

No Lab may have a deliverable that cannot be produced without technology. Strike any platform from the scope and read the output list again. If anything disappears, the Lab is designed wrong and gets rescoped before it is sold.

Rule three

Sequence is the product

Vocabulary early, consequence late. A room that has not accepted the premise cannot make the decision that rests on it. Most of the design work is placement work.

The four Labs

Each one decides something the next one needs

Every Lab is contracted individually. There is no series minimum and no bundle requirement. You can stop after any Lab, and that is a feature rather than a concession.

Lab 1

Patient Opportunity

What it decides. Where the eligible population is created, how it is found, and who owns each transition in that sequence.

TriggerNone. The only Lab that runs on the executive room alone.
DurationSix facilitated hours, single day, in person strongly preferred.
Runs onPublished registry and epidemiology, category and treatment guidelines, your own market research and prior advisory work.
FrameworkThe Four States of Eligibility™
Lab 2

Distribution Architecture

What it decides. How the product physically reaches the patient, which networks nest inside which, and what each path can and cannot tell you afterwards.

Runs onPublished manufacturer program materials, analog uptake and pricing precedent, your own channel history.
FrameworkThe Distribution Architecture Stack™
    Outputs
  • The distribution position, expressed as a vector rather than a label, with the nested networks named
  • Data rights level stated honestly per path, with the question each level cannot answer written next to it
Lab 3

Leakage Architecture

What it decides. Where the journey leaks, who owns each seam, how affordability is designed, and what gets specified into service provider contracts.

TriggerRegulatory submission, or the specialty pharmacy funding gate.
Pre-workFour to five weeks. The heaviest advisory load in the series.
FrameworksThe Transaction Chain™, The Affordability Grid™, The Silent Leak™, the Five Layers of GTN™
    Outputs
  • The access architecture and the patient journey designed rather than inherited
  • The gross-to-net architecture beneath it
  • A specialty pharmacy scorecard ready to run against RFP responses
  • The field-level data specification
Lab 4

Launch Readiness

What it decides. What gets measured, what gets inferred, what stays dark, and how field and program resources are deployed against it.

TriggerRegulatory filing acceptance. Acceptance sets the launch clock.
DurationTwo days.
Pre-workFour weeks. Site tiering on observed testing and prescribing concentration, field model and footprint scenarios.
FrameworkThe Three Tiers of Visibility™
    Outputs
  • The measurement ledger, with every observed field carrying a named supplying party and the contract clause that obligates it
  • The engagement model
  • Site prioritization tied to observed behavior

Scope, stated plainly

What is sold, and what is not

Most advisory disappointment comes from a boundary nobody drew. Here is ours, before you ask.

Sold

Frameworks, facilitation, senior pre-work, synthesis, and the decision record.

Optional

An intelligence instance and its data modules, elected at the Lab that consumes them.

Not sold

Implementation, agency-of-record scope, hub or specialty pharmacy operations, staffing.

Never

A function you will later hire. We do not build a dependency you have to buy out of.

The room

Eight to twelve people. The same core across all four Labs, with function-specific additions per Lab.

The characteristic client is a lean commercial organization with more functional opinions than functional alignment, about to scale headcount and vendor commitments around positions nobody has formally taken.

On the optional platform

NaviCuris™ is an intelligence module a client may elect at any Lab. It makes a Lab sharper. It is never what makes a Lab work.

It identifies the patient through a dynamic lens rather than a static data point. The system does not generate facts. It resolves a question against a governed relational store, and returns retrieved values, each with lineage back to the source.

Start with Lab 1

It needs no trigger, no data and no platform. Six hours and the right eight people in a room, deciding where the eligible population actually comes from.

Schedule an alignment discussion